Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders.
Iwayama H, Ishihara N, Kawahara K, Madokoro Y, Togawa Y, Muramatsu K, Murakami A, Kuru S, Kumagai T, Ohashi W, Nanya K, Hasegawa S, Katsuno M, Okumura A.
Iwayama H, et al. Among authors: togawa y.
Front Immunol. 2022 Sep 29;13:996134. doi: 10.3389/fimmu.2022.996134. eCollection 2022.
Front Immunol. 2022.
PMID: 36248823
Free PMC article.